Charles Schwab Investment Management Inc Vertex Pharmaceuticals Inc Transaction History

Charles Schwab Investment Management Inc

  • $521 Billion
  • Q1 2025

A detailed history of Charles Schwab Investment Management Inc transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 1,725,281 shares of VRTX stock, worth $768 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares
1,725,281
Previous 1,663,849 3.69%
Holding current value
$768 Million
Previous $670 Million 24.84%
% of portfolio
0.16%
Previous 0.13%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 09, 2025
BUY
$402.49 - $513.76 $24.7 Million - $31.6 Million
61,432 Added 3.69%
1,725,281 $836 Million
Q4 2024

Feb 06, 2025
BUY
$396.64 - $516.74 $14.9 Million - $19.4 Million
37,502 Added 2.31%
1,663,849 $670 Million
Q3 2024

Nov 12, 2024
BUY
$460.0 - $505.78 $9.37 Million - $10.3 Million
20,361 Added 1.27%
1,626,347 $756 Million
Q2 2024

Aug 12, 2024
BUY
$392.81 - $485.53 $19.4 Million - $24 Million
49,374 Added 3.17%
1,605,986 $753 Million
Q1 2024

May 08, 2024
BUY
$407.69 - $446.08 $19.3 Million - $21.1 Million
47,406 Added 3.14%
1,556,612 $651 Million
Q4 2023

Feb 06, 2024
BUY
$343.0 - $410.68 $14.3 Million - $17.2 Million
41,778 Added 2.85%
1,509,206 $614 Million
Q3 2023

Nov 08, 2023
BUY
$338.18 - $362.46 $5.94 Million - $6.37 Million
17,564 Added 1.21%
1,467,428 $510 Million
Q2 2023

Aug 09, 2023
BUY
$314.42 - $351.91 $2.12 Million - $2.37 Million
6,727 Added 0.47%
1,449,864 $510 Million
Q1 2023

May 11, 2023
BUY
$283.23 - $323.1 $7.68 Million - $8.76 Million
27,109 Added 1.91%
1,443,137 $455 Million
Q4 2022

Feb 13, 2023
BUY
$285.76 - $321.48 $8.03 Million - $9.03 Million
28,088 Added 2.02%
1,416,028 $409 Million
Q3 2022

Nov 14, 2022
BUY
$273.83 - $305.53 $6.53 Million - $7.29 Million
23,848 Added 1.75%
1,387,940 $402 Million
Q2 2022

Aug 15, 2022
BUY
$234.96 - $292.55 $8.61 Million - $10.7 Million
36,626 Added 2.76%
1,364,092 $384 Million
Q1 2022

May 13, 2022
BUY
$221.42 - $260.97 $14.6 Million - $17.2 Million
65,778 Added 5.21%
1,327,466 $346 Million
Q4 2021

Feb 11, 2022
BUY
$177.01 - $223.45 $3.49 Million - $4.4 Million
19,703 Added 1.59%
1,261,688 $277 Million
Q3 2021

Nov 16, 2021
BUY
$181.39 - $202.99 $4.63 Million - $5.19 Million
25,546 Added 2.1%
1,241,985 $225 Million
Q2 2021

Aug 16, 2021
BUY
$187.49 - $221.1 $1.88 Million - $2.21 Million
10,014 Added 0.83%
1,216,439 $245 Million
Q1 2021

May 17, 2021
SELL
$207.02 - $241.31 $11.2 Million - $13.1 Million
-54,152 Reduced 4.3%
1,206,425 $259 Million
Q4 2020

Feb 16, 2021
SELL
$207.01 - $276.09 $7.05 Million - $9.4 Million
-34,061 Reduced 2.63%
1,260,577 $298 Million
Q3 2020

Nov 13, 2020
BUY
$255.65 - $303.1 $15 Million - $17.8 Million
58,738 Added 4.75%
1,294,638 $352 Million
Q2 2020

Aug 14, 2020
BUY
$225.48 - $295.8 $15.9 Million - $20.8 Million
70,386 Added 6.04%
1,235,900 $359 Million
Q1 2020

May 15, 2020
BUY
$199.77 - $247.81 $7.38 Million - $9.15 Million
36,925 Added 3.27%
1,165,514 $277 Million
Q4 2019

Feb 07, 2020
BUY
$166.71 - $223.91 $3.26 Million - $4.38 Million
19,563 Added 1.76%
1,128,589 $247 Million
Q3 2019

Nov 08, 2019
BUY
$166.23 - $187.09 $6.45 Million - $7.26 Million
38,797 Added 3.63%
1,109,026 $188 Million
Q2 2019

Aug 09, 2019
BUY
$164.61 - $190.37 $2.05 Million - $2.37 Million
12,447 Added 1.18%
1,070,229 $196 Million
Q1 2019

May 14, 2019
BUY
$163.73 - $194.7 $12.9 Million - $15.4 Million
78,875 Added 8.06%
1,057,782 $195 Million
Q4 2018

Feb 14, 2019
BUY
$151.91 - $192.21 $7.06 Million - $8.94 Million
46,494 Added 4.99%
978,907 $162 Million
Q3 2018

Nov 13, 2018
BUY
$167.73 - $192.74 $4.23 Million - $4.86 Million
25,205 Added 2.78%
932,413 $180 Million
Q2 2018

Aug 08, 2018
SELL
$145.72 - $169.96 $9.29 Million - $10.8 Million
-63,727 Reduced 6.56%
907,208 $154 Million
Q1 2018

May 07, 2018
BUY
$151.6 - $177.13 $3 Million - $3.5 Million
19,759 Added 2.08%
970,935 $158 Million
Q4 2017

Jan 17, 2018
BUY
$137.28 - $155.55 $3.58 Million - $4.06 Million
26,101 Added 2.82%
951,176 $143 Million
Q3 2017

Nov 13, 2017
BUY
$148.13 - $162.24 $137 Million - $150 Million
925,075
925,075 $141 Million

Others Institutions Holding VRTX

# of Institutions
1,832
Shares Held
233M
Call Options Held
1.38M
Put Options Held
1.08M
View Full List

About VERTEX PHARMACEUTICALS INC

VRTX Quotes by TradingView
  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $114B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email